Rehmann Capital Advisory Group’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $286K | Hold |
1,693
| – | – | 0.01% | 564 |
|
|
2025
Q4 | $286K | Sell |
1,693
-1
| -0.1% | -$162 | 0.01% | 546 |
|
|
2025
Q3 | $245K | Hold |
1,694
| – | – | 0.01% | 564 |
|
|
2025
Q2 | $214K | Sell |
1,694
-296
| -15% | -$36.3K | 0.01% | 566 |
|
|
2025
Q1 | $255K | Buy |
1,990
+1
| +0.1% | +$136 | 0.02% | 524 |
|
|
2024
Q4 | $263K | Sell |
1,989
-473
| -19% | -$66.5K | 0.02% | 507 |
|
|
2024
Q3 | $359K | Sell |
2,462
-66
| -3% | -$9.55K | 0.02% | 419 |
|
|
2024
Q2 | $347K | Buy |
+2,528
| New | +$337K | 0.02% | 412 |
|
|
2022
Q1 | – | Sell |
-2,207
| Closed | -$337K | – | 553 |
|
|
2021
Q4 | $337K | Sell |
2,207
-61
| -3% | -$9.44K | 0.03% | 411 |
|
|
2021
Q3 | $367K | Sell |
2,268
-2,757
| -55% | -$464K | 0.03% | 390 |
|
|
2021
Q2 | $828K | Buy |
5,025
+2,168
| +76% | +$334K | 0.08% | 215 |
|
|
2021
Q1 | $430K | Buy |
2,857
+62
| +2% | +$9.85K | 0.04% | 325 |
|
|
2020
Q4 | $423K | Buy |
2,795
+593
| +27% | +$84.7K | 0.05% | 302 |
|
|
2020
Q3 | $298K | Buy |
2,202
+31
| +1% | +$4.21K | 0.04% | 325 |
|
|
2020
Q2 | $297K | Buy |
+2,171
| New | +$277K | 0.04% | 323 |
|
|
2019
Q3 | – | Sell |
-2,450
| Closed | -$267K | – | 1860 |
|
|
2019
Q2 | $267K | Buy |
2,450
+970
| +66% | +$103K | 0.03% | 377 |
|
|
2019
Q1 | $166K | Buy |
1,480
+602
| +69% | +$66K | 0.02% | 456 |
|
|
2018
Q4 | $84.7K | Sell |
878
-988
| -53% | -$105K | 0.01% | 446 |
|
|
2018
Q3 | $228K | Sell |
1,866
-332
| -15% | -$39.1K | 0.03% | 370 |
|
|
2018
Q2 | $241K | Buy |
2,198
+353
| +19% | +$37.8K | 0.04% | 328 |
|
|
2018
Q1 | $197K | Buy |
+1,845
| New | +$205K | 0.03% | 371 |
|
|
2017
Q2 | – | Sell |
-2,451
| Closed | -$240K | – | 393 |
|
|
2017
Q1 | $240K | Sell |
2,451
-102
| -4% | -$9.77K | 0.04% | 330 |
|
|
2016
Q4 | $226K | Buy |
+2,553
| New | +$232K | 0.04% | 342 |
|
|
2015
Q3 | – | Sell |
-1,788
| Closed | -$220K | – | 351 |
|
|
2015
Q2 | $220K | Sell |
1,788
-567
| -24% | -$67.9K | 0.05% | 293 |
|
|
2015
Q1 | $269K | Buy |
2,355
+138
| +6% | +$15.2K | 0.06% | 254 |
|
|
2014
Q4 | $224K | Sell |
2,217
-534
| -19% | -$51.9K | 0.05% | 294 |
|
|
2014
Q3 | $251K | Sell |
2,751
-96
| -3% | -$8.43K | 0.06% | 266 |
|
|
2014
Q2 | $244K | Buy |
+2,847
| New | +$224K | 0.06% | 275 |
|
|
2014
Q1 | – | Sell |
-2,784
| Closed | -$211K | – | 332 |
|
|
2013
Q4 | $211K | Sell |
2,784
-1,212
| -30% | -$86K | 0.06% | 271 |
|
|
2013
Q3 | $279K | Buy |
+3,996
| New | +$262K | 0.09% | 199 |
|
Other funds holding IBB
CB
Rehmann Capital Advisory Group's IBB Position: Q1 2026 in Review
Rehmann Capital Advisory Group held its iShares Biotechnology ETF (IBB) position steady in Q1 2026 at 1,693 shares worth $286K. The position accounts for 0.01% of the portfolio, ranked #564.
Rehmann Capital Advisory Group first reported a position in IBB in Q3 2013 and has held it in 30 quarters since. The position peaked at $828K in Q2 2021. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.
- Rehmann Capital Advisory Group held 1,693 shares of iShares Biotechnology ETF worth $286K as of Q1 2026.
- Rehmann Capital Advisory Group left its iShares Biotechnology ETF share count unchanged in Q1 2026.
- iShares Biotechnology ETF made up 0.01% of Rehmann Capital Advisory Group's portfolio in Q1 2026, its #564 holding.
- Rehmann Capital Advisory Group first reported a position in iShares Biotechnology ETF in Q3 2013 and has held it in 30 quarters since.
- Rehmann Capital Advisory Group's iShares Biotechnology ETF position peaked at $828K in Q2 2021.
- 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.
Based on Rehmann Capital Advisory Group's 13F filing for Q1 2026, filed 15 May 2026.